Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-04-25

Clinical Trial Update: GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice

View source ↗

Summary

The Bayer-sponsored clinical trial GLucobay M evaluating safety and effectiveness in adults with type 2 diabetes not well controlled on monotherapy in real-worl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLucobay M (acarbose)

Snippet

Sponsor: Bayer | Conditions: Diabetes Mellitus, Type 2 | Status: WITHDRAWN